Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer

[41] Hirsch FR(2013)Clinical significance of the expression of Alpha-methylacyl-CoA Racemase in Squamous Cell Carcinoma and Adenocarcinoma of the Lung Acta Chir Belg 113 263-66

[42] Scagliotti GV(2017)The perilipin family of lipid droplet proteins: Gatekeepers of intracellular lipolysis BBA-Mol Cell Biol L 1862 1221-1139

[43] Mulshine JL(1995)Long-term survival in small-cell lung-cancer - posttreatment characteristics in patients surviving 5 to 18+ years - an analysis of 1,714 consecutive patients J Clin Oncol 13 1215-undefined

[44] Kwon R(2020)The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis Ann Thorac Cardiovasc Surg 26 1-undefined

[45] Curran WJ(2018)Metformin for non-small cell lung cancer patients: Opportunities and pitfalls Crit Rev Oncol Hematol 125 41-undefined

[46] Wu Y-L(2008)The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition J Thorac Oncol 3 457-undefined

[47] Hung J-Y(2020)Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy J Cancer Res Ther 16 1134-undefined

[48] Chiang S-R(undefined)undefined undefined undefined undefined-undefined

[49] Liu K-T(undefined)undefined undefined undefined undefined-undefined

[50] Tsai M-J(undefined)undefined undefined undefined undefined-undefined

[41] Hirsch FR(2013)Clinical significance of the expression of Alpha-methylacyl-CoA Racemase in Squamous Cell Carcinoma and Adenocarcinoma of the Lung Acta Chir Belg 113 263-66

[42] Scagliotti GV(2017)The perilipin family of lipid droplet proteins: Gatekeepers of intracellular lipolysis BBA-Mol Cell Biol L 1862 1221-1139

[43] Mulshine JL(1995)Long-term survival in small-cell lung-cancer - posttreatment characteristics in patients surviving 5 to 18+ years - an analysis of 1,714 consecutive patients J Clin Oncol 13 1215-undefined

[44] Kwon R(2020)The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis Ann Thorac Cardiovasc Surg 26 1-undefined

[45] Curran WJ(2018)Metformin for non-small cell lung cancer patients: Opportunities and pitfalls Crit Rev Oncol Hematol 125 41-undefined

[46] Wu Y-L(2008)The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition J Thorac Oncol 3 457-undefined

[47] Hung J-Y(2020)Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy J Cancer Res Ther 16 1134-undefined

[48] Chiang S-R(undefined)undefined undefined undefined undefined-undefined

[49] Liu K-T(undefined)undefined undefined undefined undefined-undefined

[50] Tsai M-J(undefined)undefined undefined undefined undefined-undefined